IGF1-LR3

IGF-1 LR3 – Long-Arg3 Insulin-Like Growth Factor for Advanced Cellular and Growth Research

Overview:
IGF-1 LR3 (Long-Arginine3 Insulin-Like Growth Factor-1) is a synthetic research peptide developed to extend the biological activity of native IGF-1. It is widely studied in the fields of cellular growth, protein synthesis, and metabolic signaling, offering researchers valuable insight into mechanisms underlying cell proliferation, muscle differentiation, and tissue regeneration.

Due to its structural modification—substituting arginine at position three and extending the amino acid chain—IGF-1 LR3 demonstrates greater stability and a longer half-life, allowing for deeper exploration of its receptor interactions and growth-related pathways in controlled laboratory settings.

Scientific Background:
IGF-1 LR3 functions as a potent anabolic and mitogenic signaling molecule, binding to IGF-1 receptors and influencing PI3K/Akt and MAPK pathways. Research has examined its role in cell growth, DNA synthesis, glucose metabolism, and tissue adaptation processes. It has become a cornerstone peptide in studies focused on muscle physiology, neural repair, and anti-catabolic regulation.

Why Researchers Study IGF-1 LR3:
IGF-1 LR3 provides a highly stable framework for examining how growth factor peptides regulate cellular function and energy metabolism. Its enhanced bioavailability allows for extended study of long-term anabolic signaling, cell recovery, and metabolic optimization. As a key component in biochemical and physiological research, IGF-1 LR3 continues to expand understanding of cellular rejuvenation and growth factor biology.

For Laboratory Research Use Only. Not for Human Consumption.